Oxygen Desaturation During Hemodialysis

Completed

• Conditions: Renal Disease; Hypoxia

• Registration Number: NCT02501044
• Lead Sponsor: Renal Research Institute

Brief Summary

Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues.

The investigators hypothesize that:

1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of adverse outcomes in hemodialysis patients.

2. There may be demographic, anthropometric, clinical, treatment prescription, lab analytical, and other parameters that correlate with the number and severity of deoxygenation episodes and, therefore, may be used for risk stratification. Further, some of these parameters may be modifiable.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01
• Primary Completion: 2015-01
• Study Completion: 2015-01
• Status Verified: 2015-07
• Study First Submitted: 2015-07-09
• Study First Submitted QC: 2015-07-15
• Last Update Submitted: 2015-07-15
• Study First Posted: 2015-07-17
• Last Update Posted: 2015-07-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5500

Inclusion Criteria

• Hemodialysis patient

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cumulative number of deoxygenation episodes	Up to 36 months	Crit-Line III monitor recordings (which contain oxygen saturation data) will be extracted from the RRI database and the cumulative number of deoxygenation episodes will be analyzed.

Trial Locations

Locations (1)

Renal Research Institute; 🇺🇸 New York, New York, United States